FY2018 EPS Estimates for Humana Inc Lowered by Jefferies Group (HUM)

Humana Inc (NYSE:HUM) – Jefferies Group decreased their FY2018 EPS estimates for Humana in a report issued on Thursday. Jefferies Group analyst D. Windley now anticipates that the insurance provider will post earnings per share of $14.09 for the year, down from their prior forecast of $14.35. Jefferies Group has a “Buy” rating and a $221.00 price objective on the stock. Jefferies Group also issued estimates for Humana’s Q4 2018 earnings at $2.83 EPS.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, topping the consensus estimate of $2.00 by $0.06. The business had revenue of $13.19 billion during the quarter, compared to analysts’ expectations of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the company posted $2.34 earnings per share.

Several other analysts have also recently commented on HUM. Cantor Fitzgerald restated a “hold” rating and set a $250.00 price target on shares of Humana in a report on Wednesday, February 7th. Deutsche Bank raised their price target on shares of Humana from $259.00 to $270.00 and gave the stock a “hold” rating in a report on Friday. Leerink Swann raised their price target on shares of Humana from $280.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday. Credit Suisse Group upgraded shares of Humana from a “neutral” rating to an “outperform” rating and reduced their target price for the company from $264.90 to $246.00 in a research note on Thursday. Finally, Oppenheimer lifted their target price on shares of Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a research note on Thursday. Eight equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $269.68.

Shares of Humana (NYSE:HUM) opened at $265.32 on Monday. The company has a current ratio of 1.85, a quick ratio of 1.61 and a debt-to-equity ratio of 0.48. The company has a market cap of $36,528.92, a P/E ratio of 22.70, a P/E/G ratio of 1.44 and a beta of 0.93. Humana has a fifty-two week low of $203.36 and a fifty-two week high of $293.35.

Several large investors have recently added to or reduced their stakes in the company. ARP Americas LP raised its position in shares of Humana by 192.9% in the fourth quarter. ARP Americas LP now owns 4,481 shares of the insurance provider’s stock valued at $1,112,000 after purchasing an additional 2,951 shares during the period. Ontario Teachers Pension Plan Board raised its position in shares of Humana by 39.0% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 21,010 shares of the insurance provider’s stock valued at $5,212,000 after purchasing an additional 5,891 shares during the period. American International Group Inc. raised its position in shares of Humana by 3.8% in the fourth quarter. American International Group Inc. now owns 56,870 shares of the insurance provider’s stock valued at $14,108,000 after purchasing an additional 2,096 shares during the period. Arrowstreet Capital Limited Partnership raised its position in shares of Humana by 28.0% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 151,172 shares of the insurance provider’s stock valued at $37,501,000 after purchasing an additional 33,100 shares during the period. Finally, Systematic Financial Management LP bought a new position in shares of Humana in the fourth quarter valued at approximately $19,100,000. 94.13% of the stock is currently owned by institutional investors.

In other news, SVP Brian P. Leclaire sold 1,679 shares of Humana stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total value of $412,983.63. Following the transaction, the senior vice president now owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Jody L. Bilney sold 7,054 shares of Humana stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the completion of the transaction, the senior vice president now directly owns 11,704 shares in the company, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. In the last three months, insiders sold 10,115 shares of company stock worth $2,501,627. Insiders own 0.80% of the company’s stock.

Humana declared that its board has approved a share buyback plan on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a $0.50 dividend. The ex-dividend date is Wednesday, March 28th. This is a boost from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.75%. Humana’s payout ratio is 9.59%.

COPYRIGHT VIOLATION NOTICE: “FY2018 EPS Estimates for Humana Inc Lowered by Jefferies Group (HUM)” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/12/fy2018-eps-estimates-for-humana-inc-lowered-by-jefferies-group-hum.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply